Publications by authors named "Matthew Utter"

Claim this Profile
C
Cancer cells with defective RB and CDKN2A are resistant to the apoptotic effects of rapamycin.
Sohag Chakraborty, Matthew B Utter, Maria A Frias, David A Foster

Cancer Lett· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids.
Maria A Frias, Suman Mukhopadhyay, Elyssa Lehman, Aleksandra Walasek, Matthew Utter

J Biol Chem· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated phospholipase D activity in androgen-insensitive prostate cancer cells promotes both survival and metastatic phenotypes.
Matthew Utter, Sohag Chakraborty, Limor Goren, Lucas Feuser, Yuan-Shan Zhu

Cancer Lett· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of AKT phosphorylation restores rapamycin-based synthetic lethality in SMAD4-defective pancreatic cancer cells.
Onica Le Gendre, Ayisha Sookdeo, Stephie-Anne Duliepre, Matthew Utter, Maria Frias

Mol Cancer Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis